QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

22,525 signal articles · 90 in last 24h · 108,071 total before filter · latest 1h ago
90last 24h
2588last 7d
487● bullish (7d)
236● bearish (7d)
202publishers
AllMacro224Earnings1621M&A119Regulatory15Product10Analyst25
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearishshow all (incl. clickbait)
RE/MAX (RMAX): Buy, Sell, or Hold Post Q1 Earnings?
StockStory25d agoneutral
RE/MAX (RMAX): Buy, Sell, or Hold Post Q1 Earnings?

Over the past six months, RE/MAX has been a great trade, beating the S&P 500 by 29.9%. Its stock price has climbed to $11.26, representing a healthy 38.2% increase. This run-up might have investors contemplating their next move.

The PNC Financial Services Group Q2 Earnings Call Highlights
MarketBeat25d agoneutral
The PNC Financial Services Group Q2 Earnings Call Highlights

The PNC Financial Services Group (NYSE:PNC) reported what Chairman and CEO Bill Demchak called an “impressive” second quarter, with management pointing to broad-based business momentum, stronger fee income, continued commercial loan growth and stable credit quality. PNC generated second-quarter net

Morgan Stanley Q2 Earnings Call Highlights
MarketBeat25d agoneutral
Morgan Stanley Q2 Earnings Call Highlights

Morgan Stanley (NYSE:MS) reported record second-quarter 2026 results, with executives citing strong client activity across institutional securities, wealth management and investment management, as well as continued benefits from the firm’s integrated business model. Chairman and Chief Executive Off

Johnson & Johnson Q2 Earnings Call Highlights
MarketBeat25d agoneutral
Johnson & Johnson Q2 Earnings Call Highlights

Johnson & Johnson (NYSE:JNJ) raised its full-year 2026 outlook after reporting second-quarter sales growth that management said was supported by strength in Innovative Medicine, new product launches and a broad portfolio that helped offset continued pressure from STELARA biosimilar competition.

BlackRock Q2 Earnings Call Highlights
MarketBeat25d agoneutral
BlackRock Q2 Earnings Call Highlights

BlackRock (NYSE:BLK) executives said the asset manager delivered record second-quarter results and its strongest first half on record, driven by broad-based client inflows, higher markets, acquisitions and continued demand for ETFs, private markets and technology offerings. Chief Financial Officer

ASML Just Raised Guidance Again — Is This the Strongest AI Stock Story Nobody’s Talking About?
24/7 Wall St.25d agoneutral
ASML Just Raised Guidance Again — Is This the Strongest AI Stock Story Nobody’s Talking About?

The AI investment boom has created a sharp divide between companies benefiting from long-term demand and those merely riding short-term enthusiasm. While many technology businesses continue spending hundreds of billions of dollars on AI infrastructure, investors have increasingly questioned whether those investments will eventually slow. Yet every quarter seems to produce another reminder that the ... ASML Just Raised Guidance Again — Is This the Strongest AI Stock Story Nobody’s Talking About?

Why Elevance Earnings Gave Health Insurance Stocks A Cold; UNH Up Next
Investor's Business Daily25d agoneutral
Why Elevance Earnings Gave Health Insurance Stocks A Cold; UNH Up Next

Elevance Health topped Q2 earnings estimates Wednesday, despite falling medical membership, but profit was boosted by one-time "below-the-line" factors and the full-year outlook was underwhelming. ELV stock tumbled, making it among the S&P 500's early laggards. Molina Healthcare, another S&P 500 managed care stock, joined Elevance among the biggest laggards performers in pre-market trading.

ASML financial guidance includes Terafab plans, CFO says
Reuters25d agoneutral
ASML financial guidance includes Terafab plans, CFO says

Top computer chip equipment maker ASML said its ‌capacity expansion plans in 2027 and ‌2028 unveiled on Wednesday along with second-quarter earnings ​take into account demand for its tools from Elon Musk's planned Terafab chip production facility in Texas. "We're in dialogue with ‌all our ⁠customers and we know ... what their building plans are," Chief Financial ⁠Officer Roger Dassen said on a call.